Takeda Pharmaceutical Co Ltd (TAK)

Stock price, financials, and technical signals for Takeda Pharmaceutical Co Ltd (TAK).

Twitter
Facebook
Email
FinancialsNews & SentimentProCandlestick ProbabilityElite

¥14.72

-0.47

(-3.09%)

As of 04/04/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

TAK Performance Snapshot

1-Week Chg

-2.19%

1-Month Chg

-0.74%

3-Month Chg

11.01%

6-Month Chg

2.01%

1-Year Chg

9.20%

Year-To-Date Chg

11.09%

Beta 1-Year

0.07

Beta 5-Year

0.26

Volatility (10-Day)

0.86%

TAK Technicals

Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-04-04

¥14.72

-¥0.47 (-3.09%)

¥14.97

¥15.20

¥14.72

¥14.88

4.27M (¥62.79M)

2025-04-03

¥15.19

¥0.21 (1.4%)

¥15.28

¥15.37

¥15.09

¥15.22

4.31M (¥65.42M)

2025-04-02

¥14.98

¥0.08 (0.54%)

¥15

¥15.06

¥14.89

¥14.98

1.11M (¥16.69M)

2025-04-01

¥14.90

¥0.03 (0.2%)

¥15

¥15.02

¥14.88

¥14.93

1.37M (¥20.49M)

2025-03-31

¥14.87

-¥0.18 (-1.2%)

¥14.87

¥14.96

¥14.75

¥14.86

1.77M (¥26.30M)

2025-03-28

¥15.05

-¥0.09 (-0.59%)

¥15.12

¥15.12

¥14.89

¥15.02

935.36K (¥14.08M)

2025-03-27

¥15.14

¥0.12 (0.8%)

¥14.97

¥15.17

¥14.97

¥15.09

1.27M (¥19.29M)

2025-03-26

¥15.02

-¥0.02 (-0.13%)

¥14.99

¥15.05

¥14.90

¥14.99

1.58M (¥23.70M)

2025-03-25

¥15.04

¥0.03 (0.2%)

¥15.10

¥15.15

¥15.01

¥15.07

1.70M (¥25.55M)

2025-03-24

¥15.01

-¥0.18 (-1.18%)

¥15.09

¥15.13

¥15

¥15.05

1.10M (¥16.45M)

TAK Financials

Balance Sheet

(JPY)

2024 Q4

Y/Y CHANGE

  • Cash and equivalents

    ¥494.13B

    71.36%

  • Total assets

    ¥15.11T

    6.21%

  • Total liabilities

    ¥7.69T

    2.77%

  • Total investments

    ¥442.83B

    10.17%

  • Shareholders' equity

    ¥7.42T

    10.03%

  • Book value per share

    ¥2.33K

    8.51%

Income Statement

(JPY)

2024 Q4

Y/Y CHANGE

  • Revenue

    ¥1.14T

    2.96%

  • Net income

    ¥23.84B

    -77.46%

  • Operating expense

    ¥660.31B

    5.35%

  • Gross profit

    ¥727.25B

    -0.61%

  • EBITDA

    ¥244.96B

    -22.21%

  • Earnings per share

    ¥7.43

    -78.01%

Cash Flow

(JPY)

2024 Q4

Y/Y CHANGE

  • Net change in cash

    -¥387.77B

    -1359.04%

  • Cash from operations

    ¥383.76B

    97.99%

  • Cash from investing

    -¥115.56B

    -53.52%

  • Cash from financing

    -¥655.97B

    -571.00%

  • Free cash flow

    ¥338.68B

    130.37%

  • Free cash flow per share

    ¥106.44

    127.17%

Metrics

(JPY)

2024 Q4

Y/Y CHANGE

  • Market capitalization

    ¥42.13B

    -5.91%

  • Enterprise value

    ¥74.71B

    -6.35%

  • Shares outstanding

    1.59B

    1.41%

  • Profit margin

    2.10%

    -77.89%

  • Gross margin

    63.60%

    -3.34%

  • EBITDA margin

    21.40%

    -24.38%

Dividends

(JPY)

2024 Q4

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    ¥0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    1.31

    23.40%

View All Financials
Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.

Cookie Policy